Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2016 Apr 5;14(7):1035–1043. doi: 10.1016/j.cgh.2016.03.040

Figure 2.

Figure 2

Incidence of any denial of a direct-acting antiviral (DAA) prescription by the insurer (overall height of bar), insurer denial of a DAA prescription preceding approval (light gray bar), and absolute denial of a DAA prescription by the insurer (dark gray bar), overall and by insurance status.